Real-World Results of Ocrelizumab Treatment for Primary Progressive Multiple Sclerosis

BACKGROUND: Recently, ocrelizumab (Ocrevus®) was approved for the treatment of primary progressive multiple sclerosis (PPMS) based on data from the ORATORIO clinical trial. Real-world data about the clinical effectiveness of ocrelizumab has yet to be gathered. OBJECTIVE: The aim of this study was to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mult Scler Int
Main Authors: Daniels, K., van der Nat, P. B., Frequin, S. T. F. M., van der Wees, P. J., Biesma, D. H., Hoogervorst, E. L. J., van de Garde, E. M. W.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7313157/
https://ncbi.nlm.nih.gov/pubmed/32607256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/5463451
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados